Stay updated on AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Sign up to get notified when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.

Latest updates to the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe latest version label on the page has been updated to Revision: v3.5.4, replacing the previous v3.5.3. This reflects a minor site maintenance update rather than changes to the study information.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page was updated to a newer ClinicalTrials.gov interface revision (v3.5.3 instead of v3.5.0), indicating a site/version update rather than a change to the clinical trial record details.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was deleted from the record history.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision history now shows v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check101 days agoChange DetectedThe record history now shows the addition of version v3.4.2 and the deletion of version v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check108 days agoChange DetectedThe Record History now includes a new revision entry v3.4.1 and removes the previous v3.4.0 entry.SummaryDifference0.1%

Stay in the know with updates to AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.